Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 31;15(1):e0228101.
doi: 10.1371/journal.pone.0228101. eCollection 2020.

Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD

Sara T Ibrahim  1   2   3 , Rajkumar Chinnadurai  2   3 , Ibrahim Ali  2   3 , Debbie Payne  3 , Gillian I Rice  4 , William G Newman  5 , Eman Algohary  1 , Ahmed G Adam  1 , Philip A Kalra  2   3
Affiliations

Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD

Sara T Ibrahim et al. PLoS One. .

Abstract

Objectives: The R102G variant in complement 3 (C3) results in two allotypic variants: C3 fast (C3F) and C3 slow (C3S). C3F presents at increased frequency in patients with chronic kidney disease (CKD), our aim is to explore its role in CKD progression and mortality.

Methods: Delta (Δ) eGFR for 2038 patients in the Salford Kidney Study (SKS) was calculated by linear regression; those with ≤-3ml/min/1.73m2/yr were defined as rapid progressors (RP) and those with ΔeGFR between -0.5 and +1ml/min/1.73m2/yr, labelled stable CKD patients (SP).A group of 454 volunteers was used as a control group. In addition, all biopsy-proven glomerulonephritis (GN) patients were studied regardless of their ΔeGFR. R102G was analysed by real-time PCR, and genotypic and allelic frequencies were compared between RP and SP along with the healthy control group.

Results: There were 255 SP and 259 RP in the final cohort. Median ΔeGFR was 0.07 vs. -4.7 ml/min/1.73m2/yr in SP vs. RP. C3F allele frequency was found to be significantly higher in our CKD cohort (25.7%) compared with the healthy control group (20.6%); p = 0.008.However, there was no significant difference in C3F allele frequency between the RP and SP groups. In a subgroup analysis of 37 patients with IgA nephropathy in the CKD cohort (21 RP and 16 SP), there was a significantly higher frequency of C3F in RP 40.5% vs. 9.4% in SP; p = 0.003. In the GN group, Cox regression showed an association between C3F and progression only in those with IgA nephropathy (n = 114);HR = 1.9 (95% CI 1.1-3.1; p = 0.018) for individuals heterozygous for the C3F variant, increased further for individuals homozygous for the variant, HR = 2.8 (95% CI 1.2-6.2; p = 0.014).

Conclusion: The C3 variant R102G is associated with progression of CKD in patients with IgA nephropathy.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flowchart of patient recruitment to study 1.
Fig 2
Fig 2. Flowchart of patient recruitment to study 2.
Fig 3
Fig 3. Kaplan–Meier survival curve for progression in IgAN.
(Patients n = 114, event n = 59); Log Rank 14.8, p-value 0.001.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Reikes ST. Trends in end-stage renal disease. Epidemiology, morbidity and mortality. Postgrad Med. 2000;108(1):124–6. 10.3810/pgm.2000.07.1152 - DOI - PubMed
    1. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am SocNephrol. 2009;4 Suppl1:S5–11. - PubMed
    1. Eftimovska N, Stojceva-Taneva O, Polenakovic M. Slow progression of chronic kidney disease and what it is associated with. Prilozi. 2008;29:153–65. - PubMed
    1. Ritz E, Gross ML, Dikow R. Role of calcium-phosphorous disorders in the progression of renal failure. Kidney Int Suppl. 2005;(99):S66–70. 10.1111/j.1523-1755.2005.09912.x - DOI - PubMed
    1. Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nature Genetics. 2009;41:712–7. 10.1038/ng.377 - DOI - PMC - PubMed